WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Abrir esta carpeta y ver su contenidoInsect and arachnid bites and stings
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Cerrar esta carpetaScabicides and pediculicides
Ver el documentoBenzyl benzoate
Ver el documentoLindane
Ver el documentoPermethrin
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Permethrin

Cream, 5%

General information

Permethrin is a topical scabicidal agent for the treatment of infestations with Sarcoptes scabiei, Pediculus humanus capitis and P. humanus corporis. It acts on the nerve cell membranes of the parasites with consequent paralysis. It is more expensive than lindane and benzyl benzoate.

Absorption of permethrin is negligible following topical application.

Clinical information

Uses

Treatment of scabies and pediculosis of the scalp and body.

Dosage and administration

All doses are suitable for adults and children.

Scabies and Pediculus humanus corporis:

The cream should be massaged thoroughly into all skin surfaces, from the scalp to the soles of the feet, and left for at least 8 hours before rinsing. In general, 30 g is sufficient for an average adult. A single application is usually curative.

Pediculus humanus capitis:

The cream should be massaged into damp hair and left for 10 minutes before rinsing.

Household contacts should be treated at the same time. All combs and brushes should be soaked in a pediculicidal solution (see Parasitic infections - Prevention and management) for at least 2 hours.

Contraindication

Known hypersensitivity to synthetic pyrethroids or pyrethrins.

Use in pregnancy

Safe use in pregnancy has not been demonstrated. However, since absorption is negligible, it may be used if necessary.

Precautions

Pruritus, oedema and erythema may be exacerbated.

Adverse effects

Mild and transient burning and stinging sensations may occur after treatment, particularly in cases with severe infestation.

Storage

Cream should be stored in well-closed containers, below 25 °C.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012